Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Everon Biosciences

Everon Biosciences
2010 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$5M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of innovative medicines intended to prevent age-related diseases. The company's medicines are prepared for selective elimination of senescent cells, enabling people to find a cure for Systemic Aging Syndrome and age-related pathologies.

Website
Formerly Known As
Tartis Aging
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 640 Ellicott Street
  • Suite 444
  • Buffalo, NY 14203
  • United States

+1 (716) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Everon Biosciences’s full profile, request a free trial.

Everon Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 06-Feb-2013 $5M 00.000 Completed Generating Revenue
2. Debt - General 19-Aug-2011 00.000 Completed Generating Revenue
1. Early Stage VC 01-Jan-2010 $3.86M $3.86M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Everon Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Skolkovo Foundation Limited Partner 000 0000 000000 0
Bioprocess Capital Partners Venture Capital Minority 000 0000 000000 0

Everon Biosciences Executive Team (5)

Name Title Board
Seat
Contact
Info
Alexander Polinsky Ph.D Chief Executive Officer & Co-Founder
Olga Chernova Ph.D Vice President of Research & Co-Founder
Andrei Gudkov Ph.D Co-Founder & Chief Scientific Officer
Aleksandra Kotlyarova Director, Operations

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »